(Q38997766)

English

Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.

scientific article published on 4 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Marián Švajdler

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Lijuan Wang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Benedict B Benigno

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John F McDonald

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

0 references

publication date

4 May 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

134

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

96-103

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Ovarian carcinoma diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Treatment goals in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Isolation and characterization of stem-like cells from a human ovarian cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Identification of selective inhibitors of cancer stem cells by high-throughput screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Targeting breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Therapeutics formulated to target cancer stem cells: Is it in our future?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Cancer stemness and metastasis: therapeutic consequences and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Epimorphin-induced MET sensitizes ovarian cancer cells to platinum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Regulation of mRNA translation and stability by microRNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Sequence variation among members of the miR-200 microRNA family is correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial transition in ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

The microRNA-200 family regulates epithelial to mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.055

7 January 2021

Identifiers

10.1016/J.YGYNO.2014.04.055

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802724%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38997766&oldid=1503506611"